Prospective, multi-center evaluation of the desolve NX novolimus-eluting bioresorbable coronary scaffold: principal clinical and imaging endpoints
Abizaid A, Schofer J, Meng M, Witzenbichler B, Bothelho R, Costa J, Chamie D, Medical I, Ormiston J, Verheye S. Prospective, multi-center evaluation of the desolve NX novolimus-eluting bioresorbable coronary scaffold: principal clinical and imaging endpoints. European Heart Journal 2013, 34: p5547. DOI: 10.1093/eurheartj/eht310.p5547.Peer-Reviewed Original ResearchMajor adverse cardiac eventsCoronary scaffoldsBioresorbable coronary scaffoldsCoronary artery lesionsPercutaneous coronary interventionProcedural successClinical endpointsPolylactide-based polymersVascular scaffoldsArtery lesionsBioresorbable vascular scaffoldComposite endpoint of cardiac deathAnnually to 5 yearsEndpoint of cardiac deathMultiple clinical endpointsDe novo coronary artery lesionsDrug-eluting bioresorbable vascular scaffoldsAdverse cardiac eventsLong-term scaffoldTarget lesion revascularizationNative coronary artery lesionsTarget vessel revascularizationMultiple imaging modalitiesTarget vessel MIOCT assessment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply